. Role of protein phosphatases in the activation of CFTR (ABCC7) by genistein and bromotetramisole. Am J Physiol Cell Physiol 279: C108-C119, 2000.-Genistein and bromotetramisole (Br-t) strongly activate cystic fibrosis transmembrane conductance regulator (CFTR; ABCC7) chloride channels on Chinese hamster ovary cells and human airway epithelial cells. We have examined the possible role of phosphatases in stimulation by these drugs using patchclamp and biochemical methods. Genistein inhibited the spontaneous rundown of channel activity that occurs after membrane patches are excised from cAMP-stimulated cells but had no effect on purified protein phosphatase type 1 (PP1), PP2A, PP2B, PP2C, or endogenous phosphatases when assayed as [ 32 P]PO 4 release from prelabeled casein, recombinant GST-R domain fusion protein, or immunoprecipitated full-length CFTR. Br-t also slowed rundown of CFTR channels, but, in marked contrast to genistein, it did inhibit all four protein phosphatases tested. Half-maximal inhibition of PP2A and PP2C was observed with 0.5 and 1.5 mM Br-t, respectively. Protein phosphatases were also sensitive to (ϩ)-p-Br-t, a stereoisomer of Br-t that does not inhibit alkaline phosphatases. Br-t appeared to act exclusively through phosphatases since it did not affect CFTR channels in patches that had low apparent endogenous phosphatase activity (i.e., those lacking spontaneous rundown). We conclude that genistein and Br-t act through different mechanisms. Genistein stimulates CFTR without inhibiting phosphatases, whereas Br-t acts by inhibiting a membrane-associated protein phosphatase (probably PP2C) that presumably allows basal phosphorylation to accumulate. cystic fibrosis; phosphorylation; PP2C; (iso)flavonoids; phenylimidazothiazoles; cystic fibrosis transmembrane conductance regulator THE CYSTIC FIBROSIS transmembrane conductance regulator (CFTR; ABCC7-human gene nomenclature committee) chloride channel is activated by phosphorylation (6, 43) and is gated by hydrolyzable nucleotides (1, 2, 30). Phosphorylation by protein kinase A (PKA) provides the primary stimulus for channel activation (10, 11, 39) . Protein kinase C phosphorylation modulates responsiveness of the channel to PKA (26, 31, 34, 43) . Less is known regarding the dephosphorylation of CFTR, although it is equally important for controlling CFTR activity under physiological conditions. A membrane-associated phosphatase reduces the open probability in cell-attached membrane patches and causes CFTR channels to run down rapidly when excised from cAMP-stimulated Chinese hamster ovary (CHO), airway epithelial, or human colon cells (4, 16, 32, 43, 44) . Protein phosphatases type 2A and especially 2C (PP2A and PP2C, respectively) have been implicated in regulating CFTR (7, 19, 32, 43, 45) . CFTR and PP2C are specifically coimmunoprecipitated by antibodies against the other protein, and PP2C can be copurified by nickel chelate chromatography of histidine-tagged CFTR, suggesting that they form a stable regulatory complex (52).
P]PO 4 release from prelabeled casein, recombinant GST-R domain fusion protein, or immunoprecipitated full-length CFTR. Br-t also slowed rundown of CFTR channels, but, in marked contrast to genistein, it did inhibit all four protein phosphatases tested. Half-maximal inhibition of PP2A and PP2C was observed with 0.5 and 1.5 mM Br-t, respectively. Protein phosphatases were also sensitive to (ϩ)-p-Br-t, a stereoisomer of Br-t that does not inhibit alkaline phosphatases. Br-t appeared to act exclusively through phosphatases since it did not affect CFTR channels in patches that had low apparent endogenous phosphatase activity (i.e., those lacking spontaneous rundown). We conclude that genistein and Br-t act through different mechanisms. Genistein stimulates CFTR without inhibiting phosphatases, whereas Br-t acts by inhibiting a membrane-associated protein phosphatase (probably PP2C) that presumably allows basal phosphorylation to accumulate. cystic fibrosis; phosphorylation; PP2C; (iso)flavonoids; phenylimidazothiazoles; cystic fibrosis transmembrane conductance regulator THE CYSTIC FIBROSIS transmembrane conductance regulator (CFTR; ABCC7-human gene nomenclature committee) chloride channel is activated by phosphorylation (6, 43) and is gated by hydrolyzable nucleotides (1, 2, 30) . Phosphorylation by protein kinase A (PKA) provides the primary stimulus for channel activation (10, 11, 39) . Protein kinase C phosphorylation modulates responsiveness of the channel to PKA (26, 31, 34, 43) . Less is known regarding the dephosphorylation of CFTR, although it is equally important for controlling CFTR activity under physiological conditions. A membrane-associated phosphatase reduces the open probability in cell-attached membrane patches and causes CFTR channels to run down rapidly when excised from cAMP-stimulated Chinese hamster ovary (CHO), airway epithelial, or human colon cells (4, 16, 32, 43, 44) . Protein phosphatases type 2A and especially 2C (PP2A and PP2C, respectively) have been implicated in regulating CFTR (7, 19, 32, 43, 45) . CFTR and PP2C are specifically coimmunoprecipitated by antibodies against the other protein, and PP2C can be copurified by nickel chelate chromatography of histidine-tagged CFTR, suggesting that they form a stable regulatory complex (52) .
The (iso)flavonoid genistein has attracted interest because of its ability to stimulate CFTR channels, including those with disease-causing mutations (14, 21, 23, 24, 41, 42, 50, 51) . In most preparations, genistein stimulation requires elevated PKA activity. Genistein stimulation is associated with increased phosphorylation of tryptic peptides, which also become phosphorylated during forskolin stimulation (41) . These data are consistent with phosphatase inhibition, although recent patch-clamp and biochemical studies indicate that activation of genistein is at least partially independent of phosphatase and demonstrate direct interaction of genistein with the channel (12, 14, 36, 40, (47) (48) (49) .
Wild-type and mutant CFTR channels in transfected cells are also activated by phenylimidazothiazoles such as (Ϫ)-p-bromotetramisole (Br-t) and levamisole, which are well-known inhibitors of liver, bone, and kidney (LBK) alkaline phosphatases. Although most recent data suggest that CFTR is regulated by protein phosphatases (notably PP2C and PP2A) rather than by an alkaline phosphatase, the sensitivities of protein phosphatases to Br-t have not been reported. Consequently, it remains unclear whether phenylimidazothiazoles could act through inhibition of protein phosphatases. Understanding how genistein and Br-t stimulate CFTR should clarify aspects of its regulation and could be relevant to the design of pharmacotherapies for cystic fibrosis.
In this study, we show that genistein and Br-t activate CFTR channels through distinct mechanisms. Genistein does not inhibit protein phosphatases, whereas both enantiomers of Br-t inhibit protein phosphatases at concentrations found previously to activate CFTR channels, and this probably accounts for their stimulatory effect.
MATERIALS AND METHODS
Cell culture. CHO cells stably expressing wild-type CFTR were plated at low density on glass coverslips 3-5 days before patch-clamp experiments. Baby hamster kidney (BHK) cells stably expressing wild-type CFTR were plated in 10-cmdiameter plates for use in immunoprecipitations. Cells were grown at 37°C with 5% CO 2 in modified minimal essential medium (Life Technologies) containing 5% dialyzed FBS.
Patch-clamp studies. CHO cells were placed in a recording chamber (200 l) containing (in mM) 150 NaCl, 2 MgCl 2 , and 10 N-[Tris(hydroxymethyl)methyl]-2-aminoethane-sulfonic acid (TES), pH 7.4. In most experiments, this solution also contained 0.5 mM Mg 2ϩ -ATP. Single-channel currents were recorded from cell-attached and excised patches as described previously (32) and were analyzed using DRSCAN, a pCLAMP-compatible program for analyzing long records (15) .
Phosphatases. Recombinant PP1␥ was kindly provided by Dr. P. T. W. Cohen, University of Dundee. PP2A and PP2C␣ were prepared from turkey gizzard smooth muscle, as described previously (37, 38) . PP2B was from Calbiochem (La Jolla, CA).
GST-R domain. cDNA corresponding to amino acids M645-M837 was amplified using Vent polymerase and PCR primers that contained BamH I sites for subcloning into the pGEX-2T vector. Kozak consensus sequences were also added for future studies involving expression in mammalian cells. The pGEX-2T-R domain plasmid was confirmed by DNA sequencing. HB101 cells were transformed and grown to late log phase at 30°C. GST-R domain fusion protein expression was induced for 2-3 h with 0.1 mM isopropyl ␤-D-thiogalactopyranoside. GST-R domain was purified on glutathione-Sepharose 4B (Sigma) and eluted by addition of 20 mM glutathione at 4°C according to the manufacturer's instructions.
[ 32 P]ATP (50 Ci; Amersham) in 1 ml reaction buffer containing 50 mM Tris⅐HCl, 0.1 mM EGTA, 10 mM magnesium acetate, and 0.1% ␤-mecaptoethanol (pH ϭ 7.0) for 5-12 h at 30°C. The reaction was stopped by adding 100 l of solution containing 100 mM EDTA and 100 mM sodium pyrophosphate. Free [␥-32 P]ATP was removed by passing the reaction mix through Sepharose G-50 (Pharmacia Biotech, Sweden) that had been preequilibrated with 50 mM Tris⅐HCl, 0.1 mM EGTA, 5% glycerol, and 0.1% ␤-mercaptoethanol (pH ϭ 7.0). To measure radioactivity of the purified substrates, 100 l TCA (20% wt/vol) were added to 5-or 10-l aliquots and centrifuged at 10,000 rpm for 1 min at 4°C, and the supernatant was counted by liquid scintillation. The amount of free [␥-32 P]ATP was always Ͻ1% of the total radioactivity. 4 -GST-R fusion protein was carried out under similar conditions except the reaction was terminated by adding SDS sample buffer (3% SDS, 5% ␤-mercaptoethanol, 10% glycerol, and 62.5 mM Tris ⅐ HCl, pH 6.8), and samples were subjected to SDS-PAGE (12%) and autoradiography.
Dephosphorylation of immunoprecipitated (full-length) CFTR. After cells were lysed with 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 150 mM NaCl, 20 mM Tris ⅐ HCl (pH ϭ 8), 0.25 mM phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, and 2 g/ml aprotinin (RIPA buffer), CFTR was immunoprecipitated on protein G-Sepharose 4B beads using the monoclonal antibody M3A7 (27) . CFTR was phosphorylated while still on the beads by incubation with 180 nM PKA catalytic subunit, 20 M ATP, 10 Ci [␥-32 P]ATP, 10 g BSA, 140 mM NaCl, 4 mM KCl, 2 mM MgCl 2 , 0.5 mM CaCl 2 , and 10 mM Tris, pH 7.4, for 1 h at 22°C. The reaction was stopped as before, and the beads were carefully washed with RIPA buffer to remove PKA and then incubated in buffer (140 mM NaCl and 10 mM TES) containing 2 nM PP2A and 2 mM MgCl 2 or, alternatively, 10 nM PP2C and 10 mM MgCl 2 .
Immunoprecipitates from ϳ1.5 plates (10 cm 2 ) of confluent BHK cells overexpressing wild-type CFTR were used in each experiment. The reaction was stopped by adding sample loading buffer. Samples were subjected to 6% SDS-PAGE and autoradiography to assess the amount of [ 32 P]PO 4 remaining on CFTR. Aliquots were taken from the same immunoprecipitated sample when examining dephosphorylation under various test conditions, and identical volumes were used in each lane during SDS-PAGE. This procedure provided consistent loading, as indicated by several experiments in which Western blots were carried out on the same nitrocellulose membranes used for autoradiography (e.g., see Fig. 4B ).
Preparation of CHO cell fractions for phosphatase assays. Cells were lysed by sonication in 2ϫ lysis buffer containing 100 mM Tris ⅐ HCl, pH 7.4, 4 mM EDTA, 4 mM EGTA, 2% wt/vol Nonidet P-40, and protease inhibitors. The insoluble fraction was removed by centrifugation at 3,000 g for 15 min to remove unbroken cells and nuclei. The supernatant was centrifuged at 7,800 g for 10 min to pellet the mitochondrial fraction, which was washed with lysis buffer, resuspended in 2ϫ buffer, and mixed with an equal volume of 100% glycerol. The supernatant was centrifuged again at 100,000 g for 60 min. The pellet from this spin (crude membrane fraction) was treated as described for the mitochondrial fraction. The supernatant was taken as the cytosolic fraction and was mixed with an equal volume of 100% glycerol.
Statistics. Values are presented as means Ϯ SE. Significance was assessed at the 95% confidence level using a Student's t-test.
RESULTS

Effect of genistein on CFTR channel rundown.
Rapid deactivation of CFTR channels in excised patches can be reversed by exposure to PKA and therefore reflects dephosphorylation of PKA sites by a robust, membrane-associated phosphatase activity (43) . If genistein stimulates CFTR at the level of phosphatases, it would be expected to slow the rundown of channel activity in excised patches (e.g., see Ref. 4) . To test this prediction, patches were excised from CHO cells that had been prestimulated using 10 M forskolin. Under control conditions, channel activity declined by Ͼ90% within 100 s after excision in bath solution containing 1 mM Mg 2ϩ -ATP (Fig. 1A) , as described previously (4, 43) . However, if genistein (50 M) was added to the bath once forskolin-stimulated channel activity had increased to a stable level, then CFTR channels remained active for Ͼ5 min after excision (Fig. 1B) . Genistein is a well-known tyrosine kinase inhibitor; however, tyrosine kinases were probably not involved in prolonging channel activity in isolated patches. Another broad-range tyrosine kinase antagonist, erbstatin (IC 50 ϭ 780 nM), had no effect on rundown when used at the same concentration (Fig. 1C) , nor did two other inhibitors (tyrphostin A47 and lavendustin A; data not shown).
Effect of genistein on activities of purified PP2A and PP2C. To determine if genistein directly inhibits protein phosphatases implicated in CFTR regulation, we assayed the effect of genistein on PP2A and PP2C. The amount of each phosphatase used in this and subsequent experiments was chosen based on their activities in preliminary experiments. Under control conditions, purified PP2A (0.5 nM) and PP2C (2 nM) both caused significant [ 32 P]PO 4 release from radiolabeled casein within 10 min (7%-17%, Fig. 2, A and B) . Genistein (50 M) had no effect on PP2A-catalyzed release, which was inhibited ϳ90% by calyculin A (10 nM) as expected, nor on the residual 10% phosphatase activity remaining in the presence of calyculin A. PP2C-catalyzed [ 32 P]PO 4 release from phosphocasein was also genistein insensitive (Fig. 2B) hibits dephosphorylation at the level of CFTR by making it a less effective substrate for phosphatases. Because most phosphorylation of CFTR is on the R domain, we first examined dephosphorylation of the GST-R domain fusion protein.
GST-R was radiolabeled, and its dephosphorylation was assessed by autoradiography as described in MA-TERIALS AND METHODS. The entire fusion protein was used since the R domain portion contains Ͼ97% of the radioactive phosphate after incubation with PKA and [␥- 2 and 1 vs. 4, respectively, Fig. 4A 
], as expected (lane 7). Genistein also had no detectable effect on the dephosphorylation of GST-R by PP1, PP2B, or alkaline phosphatase (lanes 8-14) . To test if genistein might protect PKA sites from PP2A or PP2C only in the full-length polypeptide, immunoprecipitated CFTR was phosphorylated in vitro and incubated with phosphatases for 15 min in the presence or absence of genistein. As shown in Fig. 4B , genistein (50 M) had no effect on dephosphorylation of full-length CFTR by PP2A or PP2C. Western blot analysis confirmed that similar amounts of CFTR had been loaded in each lane. These results indicate that genistein does not affect CFTR dephosphorylation, at least under experimental conditions in which the protein is immunoprecipitated (see below).
Effect of Br-t on CFTR channel rundown. The alkaline phosphatase inhibitor (Ϫ)-p-Br-t (2 mM) also slowed deactivation of CFTR channels in excised patches (Fig. 5) . Channel activity was sustained for Ͼ5 min in seven out of seven patches, although it eventually declined to zero, consistent with previous results (4). However, the stereoisomer (ϩ)-p-Br-t, which is often used as a negative control when assaying alkaline phosphatases, also slowed rundown. These data are consistent with recent patch-clamp studies (28) and provide further evidence that channel deactivation is not mediated by one of the "LBK" alkaline phosphatases, which are specifically inhibited by (Ϫ)-Br-t.
Effect of Br-t on purified PP2A and PP2C. Because PP2C and PP2A are the most likely candidates to be CFTR phosphatases, we investigated their sensitivities to Br-t using the protocol described above for genistein. As shown in Fig. 6A , both enantiomers reduced PP2A (0.5 nM) activity by Ͼ90%. Similar results were obtained in PP2C (2 nM) assays, although inhibition by (ϩ)-Br-t was somewhat stronger. Some dephosphorylation occurred even at the highest Br-t concentrations used, which probably explains why Br-t slows deactivation approximately fourfold in patchclamp experiments but does not completely abolish rundown (4) .
We determined the concentration dependence of Br-t inhibition (Fig. 6B) . (Ϫ)-p-Br-t was slightly more effective in inhibiting PP2C than PP2A (IC 50 values of 1 and 2 mM, respectively). Surprisingly, inhibition of PP2C by the "inactive" (ϩ)-Br-t isomer was threefold stronger than by (Ϫ)-Br-t (Fig. 6C) . Least-squares fitting yielded IC 50 ϭ 0.3 mM for (ϩ)-p-Br-t and 1 mM for (Ϫ)-p-Br-t (Fig. 6C) . Nevertheless, the concentration of (Ϫ)-Br-t required to inhibit PP2C is ϳ500-fold higher than for comparable inhibition of LBK alkaline phosphatases.
Cytosol had the strongest endogenous phosphatase activity among the cell fractions assayed during genistein experiments (see above); therefore, we examined the Br-t sensitivity of crude cytosolic extracts. Assay conditions were designed to support activity of all known protein phosphatases, i.e., Ca 2ϩ (1 mM), calmodulin (10 g/ml), and Mg 2ϩ (12 mM) were all present. Both enantiomers of Br-t inhibited release of [ 32 P]PO 4 from phosphocasein, with (ϩ)-p-Br-t being the most potent (Fig. 7) . Cytosolic phosphatase activity was nearly abolished when exposed to a mixture of known protein phosphatase inhibitors, i.e., calyculin A to inhibit PP1 and PP2A, EGTA to inhibit PP2B, and low Mg 2ϩ to inhibit PP2C.
Effect of Br-t on dephosphorylation of CFTR and GST-R domain fusion protein.
The ability of Br-t to inhibit dephosphorylation could depend on the particular substrate used in the assay; therefore, we examined its effect on dephosphorylation of both GST-R domain fusion protein and full-length CFTR. GST-R and immunoprecipitated CFTR were incubated with PKA and [␥- 32 P]ATP and then were exposed to purified Fig. 1, A and C) . B: similar inhibition was observed with (ϩ)-Br-t in 5 of 12 patches. PP2A (2 nM) or PP2C (10 nM) in the absence or presence of Br-t, as described in MATERIALS AND METHODS. Br-t strongly inhibited dephosphorylation of GST-R by all four types of protein phosphatase under these conditions (Fig. 8) . Dephosphorylation of full-length CFTR by PP2A (2 nM) and PP2C (10 nM) was also inhibited by both enantiomers (Fig. 9) . To compare the concentration dependence of Br-t inhibition more quantitatively, the IC 50 for inhibition of PP2C by each enantiomer was assessed using radiolabeled GST-R as the substrate. As shown in Fig. 10A , elevating (Ϫ)-Br-t concentration caused progressively stronger inhibition of PP2C, yielding an IC 50 ϳ0.5 mM and maximal inhibition at 2 mM. Similar results were obtained with (ϩ)-p-Br-t, although the IC 50 was somewhat lower (0.2 mM; Fig. 10B ).
DISCUSSION
Only a few potent activators of the CFTR channel have been described to date, and their mechanisms of action remain obscure. In this paper, we have examined the role of protein phosphatases in stimulation by two of these, genistein and Br-t. In addition to activating wild-type CFTR in epithelial cells, both drugs have been shown to stimulate channels with disease-associated mutations. Genistein potentiates forskolin activation of CFTR that have the most common CF mutation, Note that (ϩ)-Br-t was almost as potent as (Ϫ)-Br-t in inhibiting dephosphorylation by PP2A (0.5 nM) and was a more potent inhibitor of PP2C (2 nM) than PP2A. B: concentration dependence of PP2C (s) and PP2A (ᮀ) inhibition by (Ϫ)-Br-t. [ 32 P]PO 4 release was normalized as the ratio (amount released with PP2C ϩ Br-t )/(amount released with PP2C alone). Note that PP2C was more sensitive than PP2A. C: comparison of the inhibition of PP2C by Ϫ and ϩ enantiomers of Br-t. Data are means Ϯ SE; n ϭ 4 experiments. a deletion of phenylalanine 508 (21), whereas Br-t activates several mutants, including G551D, when cells have only basal PKA activity (4) .
Mechanisms of CFTR activation by genistein. Early evidence for genistein stimulation of CFTR came from studies of NIH/3T3 cells transfected with CFTR (24) . Addition of genistein alone stimulated 125 I efflux and CFTR channel activity in cell-attached patches, and these responses were blocked by the tyrosine phosphatase inhibitor orthovanadate. Genistein did not elevate cAMP but rather decreased the concentration of forskolin required for half-maximal stimulation. Similar results were obtained with shark rectal glands (SRG) and primary cell cultures derived from SRG (29) . The T84 cell line also responded to tyrphostin-47, another tyrosine kinase inhibitor, strengthening the idea that CFTR channels are tonically inhibited by tyrosine kinases (42); however, subsequent studies indicated that genistein has some other mode of action. The tyrosine Fig. 7 . Effect of Br-t (2 mM) on protein phosphatase activity of cytosolic fraction from Chinese hamster ovary (CHO) cells. Both enantiomers of Br-t (ϩ and Ϫ) inhibited dephosphorylation of phosphocasein when assayed in the presence of 1 mM Ca 2ϩ , 1 mM Mn 2ϩ , 12 mM Mg 2ϩ , and calmodulin. Note that inhibition by (ϩ)-Br-t was significantly stronger than by (Ϫ)-Br-t, consistent with the effects on purified PP2A in Fig. 6 and the abundance of PP2A in the cytosol. Data are means Ϯ SE; n ϭ 5. Fig. 8 . Effect of Br-t (2 mM) on dephosphorylation of GST-R domain fusion protein. GST-R was phosphorylated as in Fig. 4A , incubated with PP1 (10 nM), PP2A (2 nM), PP2B (40 nM), or PP2C (10 nM) for 10 min at 20°C in the absence or presence of (Ϫ)-Br-t, run on 12% SDS-PAGE, and exposed to X-ray film for 12 h. Both enantiomers inhibited dephosphorylation of the fusion protein. Fig. 9 . Effect of Br-t enantiomers (2 mM) on dephosphorylation of full-length CFTR. After immunoprecipitation and radiolabeling as in Fig. 4B , CFTR was incubated in control buffer (lane 1) or in solution containing PP2A (2 nM; lanes 2-6) or PP2C (10 nM; lanes 7-11) . Each incubation was carried out in duplicate with Ϫ and ϩ enantiomers of Br-t. Dephosphorylation by PP2A and PP2C was strongly inhibited by both (Ϫ)-Br-t ( lanes 3 and 4 and lanes 8 and 9 , respectively) and by (ϩ)-Br-t ( lanes 5 and 6 and lanes 10 and 11, respectively) . Fig. 10 . Concentration dependence of PP2C inhibition by Br-t enantiomers. GST-R domain protein was phosphorylated as before and then was exposed to PP2C (10 nM) for 10 min in the presence of different concentrations of Br-t. Dephosphorylation was quantified by densitometry of autoradiograms after normalizing to the control lane (no phosphatase present during 10 min incubation under same conditions). A: dephosphorylation of GST-R domain by PP2C was strongly inhibited at concentrations of (Ϫ)-Br-t Ͼ1 mM. B: (ϩ)-Br-t inhibited PP2C at similar concentrations. kinase inhibitors erbastatin, herbimycin A, tyrphostin-51, and tyrphostin-47 did not mimick genistein stimulation of CFTR channels in other cell types (12, 23, 49) . Moreover, subsequent studies with the tyrosine kinase src revealed that tyrosine phosphorylation stimulates rather than inhibits channel activity. Exposing CFTR to the tyrosine kinase p60 c-src potentiated stimulation by PKA (13) or strongly activated CFTR channels when added alone (25) . The latter stimulation was associated with phosphorylation of tyrosines on CFTR.
Genistein has been proposed to stimulate CFTR by inhibiting protein phosphatases that normally counteract its activation by PKA. This hypothesis was supported by the finding that genistein's effect on CFTR channels in NIH/3T3 and Hi-5 insect cells was greatly enhanced by cAMP stimulation (41, 50) . Genistein exposure increased CFTR phosphorylation in vivo, as assessed by metabolic labeling of cells with [ 32 P]PO 4 . Subsequent digestion by trypsin, SDS-PAGE, and TLC yielded phosphopeptide maps during genistein treatment that resembled those during forskolin stimulation (41) . Because genistein does not stimulate PKA, these results were most easily explained by inhibition of a CFTR phosphatase. Sustained CFTR-mediated currents across permeabilized T84 and HT-29/B6 cell monolayers after cAMP washout provided further support for the phosphatase hypothesis (23) .
Most recently, genistein has been shown to increase the mean open time of single CFTR channels in patches with little phosphatase activity (22) . Moreover, repeated genistein stimulations were obtained in the absence of PKA, which argues against a mechanism that requires phosphorylation/dephosphorylation (49) . Genistein further increased the activity of channels that had been stimulated by PKA and Mg 2ϩ -adenosine 5Ј-O-(3-thiotriphosphate), although the thiophosphoryl moiety would be expected to resist phosphatases (14) . On the basis of these findings, it was proposed that genistein alters CFTR gating by directly interacting with the channel, perhaps at a nucleotide binding fold (48) . Indeed, direct interaction of genistein with a fusion protein composed of the second nucleotide binding fold (NBF2) and maltose binding protein, and ATPase inhibition, have recently been demonstrated (40) . This is compatible with long open times, since inhibitors of hydrolysis at NBF2 are thought to stabilize the open state of the channel (20) . Genistein stimulation of CFTR by such a mechanism contrasts with that proposed for multidrug resistance-associated protein (MRP1), another ATP-binding cassette transport protein (18) . Genistein is thought to stimulate ATPase activity of MRP1 by interacting at the substrate binding site for drug transport rather than a NBF. There is also evidence that genistein acts on CFTR preferentially from the extracellular side (51) . Regardless of the site of interaction, direct binding of genistein to CFTR would not preclude other modes of action such as phosphatase inhibition (17, 48) .
Genistein does not inhibit protein phosphatases or dephosphorylation of immunoprecipitated CFTR.
The present results argue strongly against a role of phosphatases in the activation of CFTR by genistein. Genistein slowed channel rundown in excised patches but did not inhibit any of the purified protein phosphatases tested (PP1, PP2A, PP2B, and PP2C), nor did it affect the endogenous phosphatase activities of cell fractions. We could find no evidence that the ability of CFTR to serve as a phosphatase substrate was affected by genistein; however, extrapolating from immunoprecipitated CFTR protein to native membrane is problematic because genistein could inhibit dephosphorylation through some affect on channel gating that is disrupted by solubilization. In preliminary experiments, we found that genistein alters the digestion pattern of CFTR produced by limited proteolysis with chymotrypsin (data not shown), further evidence for genistein inducing a conformational change (40) . Although a secondary (gating-dependent) effect on phosphatase sensitivity cannot be excluded, the present data are most consistent with stimulation via direct binding of genistein to CFTR and stabilization of the open state.
Mechanism of CFTR activation by Br-t. Br-t has long been known as a potent and specific inhibitor of particular types of alkaline phosphatases (8) . LBK alkaline phosphatase activities are abolished by 0.1 mM (Ϫ)-p-Br-t, whereas intestinal and placental alkaline phosphatases are not inhibited significantly (46) . The stereoisomer (ϩ)-p-Br-t does not inhibit alkaline phosphatases and is widely used as an inactive analog. In previous work, we found that (Ϫ)-Br-t inhibits CFTR rundown in patches from CHO and human airway epithelial cells [NP34 (4, 5) ] and also activates quiescent G551D mutant channels that are normally unresponsive to forskolin. Dephosphorylation of CFTR in crude CHO cell membrane preparations was also sensitive to millimolar concentrations of (Ϫ)-Br-t. Inhibition of rundown by 1 mM (ϩ)-Br-t was not detected; however, the effects of this enantiomer on dephosphorylation of CFTR protein were not assessed.
In the present study, channel rundown and CFTR dephosphorylation were sensitive to both "active" (Ϫ) and "inactive" (ϩ)-Br-t enantiomers, suggesting LBK alkaline phosphatases are not involved. Inhibition of rundown by (ϩ)-Br-t was apparent in two-thirds of the patches and may have been more consistent than in previous experiments because of the higher concentration used (2 vs. 1 mM in Ref. 4) . In this study, we found that both enantiomers inhibit PP1, PP2A, PP2B, and PP2C and reduce activity of endogenous phosphatases in crude cell fractions by ϳ90%. Rundown in excised patches was slowed but not abolished by Br-t; therefore, the residual 10% must be sufficient to eventually cause channels to deactivate. Strong inhibition of protein phosphatases by Br-t was apparent regardless of the substrate used (phosphocasein, full-length phospho-CFTR immunoprecipitates, or phospho-GST-R domain fusion protein).
Direct evidence that Br-t stimulates CFTR by inhibiting phosphatases. Phenylimidazothiazoles (0.1-2 mM) stimulate iodide efflux and activate single CFTR channels in CFTR-expressing CHO and airway cells without elevating cAMP (4, 5) . (Ϫ)-Br-t also stimulates CFTR conductance in other preparations (28, 35) , although the response seems somewhat weaker [e.g., 15% of the forskolin response in permeabilized T84 cell monolayers (35) ]. Such variations would be expected if Br-t stimulation is indirect and mediated by inhibition of phosphatase(s) as originally proposed (4), since the responsiveness of different preparations would depend on their basal PKA activity, which in turn would reflect adenylyl cyclase and phosphodiesterase activities and perhaps other factors. The present results support the proposal that Br-t stimulates channel activity by inhibiting CFTR dephosphorylation, since it inhibited all four major types of protein phosphatases examined.
Higher concentrations of phenylimidazothiazoles are needed for activation of CFTR channels on-cell (EC 50 ϭ 450 M) than to inhibit alkaline phosphatase in biochemical assays (IC 50 Յ 11 M; see Refs. 5 and 33). We tentatively attributed this difference to a requirement for permeation through the plasma membrane during patch-clamp experiments; however, the present work shows that Br-t inhibits protein phosphatases in the test tube at similar concentrations. Thus the high IC 50 for CFTR channel activation reflects the lower sensitivity of protein phosphatases to Br-t compared with alkaline phosphatase. PP2C, which is strongly implicated in CFTR channel regulation (32, 45, 52) , was inhibited at concentrations that activate CFTR channels in cell-attached patches (5) .
Biochemical assays in the present study also revealed that Br-t inhibition of protein phosphatases is not stereospecific. This is consistent with reports that both Br-t enantiomers stimulate chloride conductance in cells expressing endogenous (35) or heterologous CFTR (9) . Thus, although the CFTR phosphatase has some functional similarities to alkaline phosphatases [negligible sensitivity to okadaic acid and calyculin A, Ca 2ϩ and calmodulin independence, Mg 2ϩ dependence, and sensitivity to a polyclonal antibody against alkaline phosphatase (3, 32, 43) ], the results of this study are more consistent with regulation by a protein phosphatase. The ability of phosphatase inhibitors to activate CFTR in unstimulated cells, at least in some cell types, implies significant turnover of phosphorylation on CFTR under resting conditions. When added alone, Br-t does not stimulate the shortcircuit current across intact T84 cell monolayers, although partial stimulation is observed when the basolateral membrane is permeabilized using nystatin (35) . We also found this negative result in early studies (Becq F, Boucher A, and Hanrahan JW, unpublished observations) and attributed it to the known insensitivity of intestinal alkaline phosphatases to Br-t. Because the present work suggests that CFTR is regulated by a Br-t-sensitive protein phosphatase, the inability of Br-t to stimulate secretion across T84 monolayers now requires some other explanation. One possibility is that Br-t also inhibits other transporters or channels, e.g., basolateral membrane potassium conductance, as recently demonstrated by Mun et al. (35) . Such inhibition by Br-t may be direct or mediated by a phosphatase, or it may involve inhibition of some enzyme critical for cellular metabolism. Regardless, inhibition of basolateral potassium channels would depolarize both basolateral and apical membranes and would diminish the apical driving force for chloride. Such depolarization could block secretion and obscure activation of CFTR channels in assays that do not involve measurement of single channel activity. The ability of Br-t to induce a current across T84 monolayers after the basolateral membrane had been nystatin permeabilized and after a transepithelial chloride gradient had been imposed supports this explanation (35) . Although patch-clamp studies suggest that phosphatase inhibitors could provide therapeutic benefit (4), the high concentrations of Br-t needed (5), offsetting effects on other channels (35) , and the sensitivity of multiple protein phosphatases (present study) indicate that Br-t itself has limited potential as a drug. Establishing the precise isoform of PP2C associated with CFTR may help in the identification of more potent and specific phosphatase inhibitors.
In summary, genistein and Br-t activate CFTR channels through different mechanisms. Genistein appears to act directly, since it did not affect phosphatases, whereas Br-t activation clearly does involve phosphatase inhibition. Br-t inhibited all protein phosphatases when tested at concentrations that stimulate CFTR channels and did not stimulate channels in patches with low endogenous phosphatase activity.
